======= MAGEC2 =======
== Gene Information ==
* **Official Symbol**: MAGEC2
* **Official Name**: MAGE family member C2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51438|51438]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBF1|Q9UBF1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MAGEC2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MAGEC2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/300468|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene is a member of the MAGEC gene family. It is not expressed in normal tissues, except for testis, and is expressed in tumors of various histological types. This gene and the other MAGEC genes are clustered on chromosome Xq26-q27. [provided by RefSeq, Oct 2009].
* **UniProt Summary**: Proposed to enhance ubiquitin ligase activity of RING- type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination in presence of Ubl-conjugating enzyme UBE2H leading to p53/TP53 degradation. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzymes (E2) at the E3:substrate complex. {ECO:0000269|PubMed:20864041}.
|MAGE|
|MAGE N|
|positive regulation of ubiquitin-protein transferase activity|
|regulation of ubiquitin-protein transferase activity|
|positive regulation of protein ubiquitination|
|positive regulation of protein modification by small protein conjugation or removal|
|regulation of protein ubiquitination|
|regulation of protein modification by small protein conjugation or removal|
|ubiquitin protein ligase binding|
|cellular protein catabolic process|
|positive regulation of transferase activity|
|protein catabolic process|
|nucleolus|
|cellular macromolecule catabolic process|
|regulation of transferase activity|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|positive regulation of protein modification process|
|positive regulation of catalytic activity|
|positive regulation of cellular protein metabolic process|
|positive regulation of protein metabolic process|
|organic substance catabolic process|
|positive regulation of molecular function|
|cellular catabolic process|
|regulation of protein modification process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp439|QNZ 0.01μM R08 exp439]]|-2.08|
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|-1.9|
|[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-1.82|
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.78|
|[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.71|
|[[:results:exp400|Senexin-A 25μM R07 exp400]]|1.71|
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|1.81|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/694
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/26|
|bone|0/26|
|breast|0/30|
|central nervous system|0/49|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/11|
|fibroblast|0/1|
|gastric|0/14|
|kidney|0/18|
|liver|0/19|
|lung|0/72|
|lymphocyte|0/16|
|ovary|0/25|
|pancreas|0/22|
|peripheral nervous system|0/15|
|plasma cell|0/12|
|prostate|0/1|
|skin|0/20|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/28|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4820
* **Expression level (log2 read counts)**: -6.02
{{:chemogenomics:nalm6 dist.png?nolink |}}